News

15 January 2021

3rd SOTAX Congress 2021 – Save the date!

Don't miss out when pharmaceutical testing experts exchange their views on current market challenges from 21 - 22 September 2021. Speakers include renowned experts from academia, industry, and regulatory agencies.

read more

25 May 2020

#

Manual dissolution with audit trail and LDAP user authentication

Connect one or multiple manual AT Xtend™ dissolution baths to a q-doc® workstation for full traceability of user actions. Started tests continue in case of network interruptions and all test results are protocolled in one location.

read more

10 May 2020

#

SOTAX participates at SPDS 8th Annual International Conference Disso India 2020

Conducted every year, this flagship conference will be attended by Pharmaceutical R&D, QA, and QC as well as academia professionals and speakers from US, Europe and Asia.

read more

01 May 2020

#

SOTAX Group acquires software specialist SECOM GmbH

The SOTAX Group takes over the software specialist SECOM GmbH to further expand its position as the world's leading solution provider for pharmaceutical test equipment.

read more

26 March 2020

SOTAX Statement on COVID-19

SOTAX continue to operate and remain accessible to customers and partners: We maintain sales, production, logistics, and all our services.

read more

01 November 2019

New partnership with Triskelion for biorelevant dissolution tests

Driving prediction forward – SOTAX announces partnership with Triskelion for In-vivo Predictive Dissolution Testing

read more

01 July 2019

#

USP Courses – Registration for dissolution courses is now open!

Two new dissolution course offerings operated by USP in cooperation with SOTAX at our Corporate Headquarters in Aesch/Basel, Switzerland.

read more

10 May 2019

Automated dissolution system & hardness tester launched in Asia

From 7-9 May, more than 40 local experts & SOTAX partners from all over Asia participated in laboratory automation & data integrity workshops - covering dissolution testing, tablet hardness testing, and automated sample preparation in Phuket, Thailand.

read more

01 May 2019

#

USP 4 – From Discovery Phase to Preclinical Development.

The flow-through cell dissolution method (USP <711>, Apparatus 4 / Ph. Eur. 2.9.3, Apparatus 4) is a well-known approach for low-solubility BCS Class II and IV active pharmaceutical ingredients (APIs) and their drug products.

read more

29 April 2019

#

Your dissolution test – only perform manually what really counts.

Whether you do routine testing in QC or need to execute DOE studies in R&D – Xtend™ allows flexible automation of your dissolution tests as needed. Standardized Xtend™ Modules can be combined to differently automated dissolution testing systems.

read more